# Growth Hormone Treatment Study in Children With Cystic Fibrosis

> **NCT00256555** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **University of Texas Southwestern Medical Center**

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Nutropin AQ

## Key facts

- **NCT ID:** NCT00256555
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2000-02
- **Primary completion:** 2018-12-12
- **Final completion:** 2018-12-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00256555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00256555, "Growth Hormone Treatment Study in Children With Cystic Fibrosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00256555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*